EWTX — Edgewise Therapeutics, Inc. stock price, charts and financials

QT84Edgewise Therapeutics, Inc.

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
43.39
-0.13-0.30%
OverviewShort InterestFilings
EWTXQT84Edgewise Therapeutics, Inc.·NASDAQ
43.39-0.30%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 06, 2026SC 13GBeneficial ownership statement (passive)
Aug 06, 20268-KCurrent report
Aug 06, 202610-QQuarterly report
Jul 17, 20264Statement of changes in beneficial ownership
Jul 16, 20268-K/ACurrent report (amended)
Jul 13, 20268-KCurrent report
Jul 02, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 16, 20264Statement of changes in beneficial ownership
Jun 16, 20264Statement of changes in beneficial ownership
Jun 16, 20264Statement of changes in beneficial ownership
Jun 05, 20268-KCurrent report
Jun 01, 20268-KCurrent report
May 15, 2026SC 13GBeneficial ownership statement (passive)
May 07, 202610-QQuarterly report
May 07, 20268-KCurrent report
May 07, 2026S-8Registration of employee benefit securities
May 05, 2026144Notice of proposed sale of restricted securities
May 05, 20264Statement of changes in beneficial ownership
Apr 27, 2026SC 13D/ABeneficial ownership statement (active, amended)
Apr 23, 2026DEFA14AAdditional proxy soliciting materials
Apr 23, 2026DEF 14ADefinitive proxy statement
#1 / 25 of 351
Page
▼
/ 15